SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales slipped to Rs. 3562.40 millions for the March 2026 quarter as against Rs. 4612.40 millions during the year-ago period.The Net Loss for the quarter ended March 2026 is Rs. -153.90 millions as compared to Net Profit of Rs. 512.20 millions of corresponding quarter ended March 2025The company reported a degrowth in operating Profit to 347.10 millions from 810.30 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 3562.40 4612.40 -22.76 14122.90 17357.00 -18.63 14122.90 17357.00 -18.63
Other Income 222.20 60.50 267.27 629.00 408.30 54.05 629.00 408.30 54.05
PBIDT 347.10 810.30 -57.16 1132.60 2947.10 -61.57 1132.60 2947.10 -61.57
Interest 40.90 15.30 167.32 118.00 76.20 54.86 118.00 76.20 54.86
PBDT 182.60 835.00 -78.13 3284.40 2910.90 12.83 3284.40 2910.90 12.83
Depreciation 289.70 274.70 5.46 1190.30 1084.10 9.80 1190.30 1084.10 9.80
PBT -107.10 560.30 -119.11 2094.10 1826.80 14.63 2094.10 1826.80 14.63
TAX 46.80 48.10 -2.70 504.70 197.20 155.93 504.70 197.20 155.93
Deferred Tax 46.80 48.10 -2.70 500.30 197.20 153.70 500.30 197.20 153.70
PAT -153.90 512.20 -130.05 1589.40 1629.60 -2.47 1589.40 1629.60 -2.47
Equity 140.80 140.80 0.00 140.80 140.80 0.00 140.80 140.80 0.00
PBIDTM(%) 9.74 17.57 -44.54 8.02 16.98 -52.77 8.02 16.98 -52.77

Unichem Lab Share Price

372.35 -0.35 (-0.09%)
04-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.35
Dr. Reddys Lab 1267.05
Cipla 1397.75
Zydus Lifesciences 1085.45
Lupin 2248.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×